BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18265455)

  • 21. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
    Raith W; Gamillscheg A; Heinzl B; Nagel BH; Koestenberger M; Beitzke A
    Klin Padiatr; 2009; 221(2):83-8. PubMed ID: 19263328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kawasaki disease: a dangerous acute childhood illness.
    Rubin B; Cotton DM
    Nurse Pract; 1998 Feb; 23(2):34, 37-8, 44-8. PubMed ID: 9513217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA antigens in mucocutaneous lymph node syndrome in New England.
    Krensky AM; Berenberg W; Shanley K; Yunis EJ
    Pediatrics; 1981 May; 67(5):741-3. PubMed ID: 7255009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kawasaki disease. Some recent studies on pathogenetic mechanisms.
    Tay JS
    J Singapore Paediatr Soc; 1990; 32(1-2):11-3. PubMed ID: 1701839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biochemical and immunological laboratory findings in Kawasaki disease].
    Ogawa S
    Nihon Rinsho; 2008 Feb; 66(2):315-20. PubMed ID: 18260330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden death caused by coronary artery aneurysms: a late complication of Kawasaki disease.
    Wreford FS; Conradi SE; Cohle SD; Lie JT; Dana SE; Puri S
    J Forensic Sci; 1991 Jan; 36(1):51-9. PubMed ID: 2007880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).
    Landing BH; Larson EJ
    Am J Cardiovasc Pathol; 1987; 1(2):218-29. PubMed ID: 3333141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J; Szymanowska Z; Mazurek A
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibody-dependent cell-mediated cytotoxicity (K-cell population) of peripheral lymphocytes in Kawasaki disease and allergic conditions. 1. Relation between K-cell population and the blood immune complex content in Kawasaki disease].
    Suzuki M
    Arerugi; 1983 Mar; 32(3):164-72. PubMed ID: 6625894
    [No Abstract]   [Full Text] [Related]  

  • 30. [The immune system in Kawasaki disease. Study of the 1st case of the disease found in Italy in an adult subject].
    Montella F; Persico L; Recchia O
    Minerva Med; 1985 Apr; 76(14-15):711-6. PubMed ID: 3873027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe triple vessel coronary artery disease and aneurysms in a young white man: disease progression of childhood Kawasaki disease.
    Sivalingam SK; Parthasarathy HK; Choong CK; Freeman LJ
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):170-3. PubMed ID: 19194177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM; Schaffer FM; Myones BL; Yount WJ; Rowe RD; Rubin L; Stein LD; Gelfand EW; Silverman ED
    Prog Clin Biol Res; 1987; 250():175-84. PubMed ID: 3423037
    [No Abstract]   [Full Text] [Related]  

  • 33. [Kawasaki disease. Immunological evaluation of 26 cases].
    Krasovec S; Bezrodnik L; Gaillard MI; Carabajal P; Ginaca A; Vainstein E
    Medicina (B Aires); 2001; 61(1):8-14. PubMed ID: 11265631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors in the development of Kawasaki disease and specificity of immunity in children].
    Matsuoka Y; Yata J
    Nihon Rinsho; 1983 Sep; 41(9):2047-51. PubMed ID: 6363750
    [No Abstract]   [Full Text] [Related]  

  • 35. Superantigens and Kawasaki disease.
    Furukawa S; Matsubara T; Yabuta K
    Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on etio and immunopathogenesis of Kawasaki disease.
    Takahashi K; Oharaseki T; Yokouchi Y
    Curr Opin Rheumatol; 2014 Jan; 26(1):31-6. PubMed ID: 24247115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The levels and relationship of anticardiolipin antibody and anti-beta 2-glycoprotein I antibody in the serum of children with Kawasaki disease].
    Liu GY; Tan Y; Du JB
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):214-5. PubMed ID: 15833202
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological status of children with Kawasaki syndrome.
    Esser M; Cotton M; Bouic P
    S Afr Med J; 1992 Feb; 81(4):229-30. PubMed ID: 1738916
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kawasaki disease as immune complex disease].
    Kato H
    Nihon Rinsho; 1983 Sep; 41(9):2052-6. PubMed ID: 6229654
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.
    Venkatraman R; Singh S; Minz RW
    Rheumatol Int; 2006 Jun; 26(8):693-6. PubMed ID: 16308701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.